Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity

American Journal of Hematology

Volumn 66, Issue 3, 2001, Pages 189-196

  Paietta, Elisabeth ^a,h   Neuberg, Donna ^b   Richards, Susan ^c   Bennett, John M ^d   Han, Lei ^e   Racevskis, Janis ^a   Dewald, Gordon ^f   Rowe, Jacob M ^g   Wiernik, Peter H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d UNIVERSITY OF ROCHESTER   (United States)

^e ABBOTT NORTHWESTERN HOSPITAL   (United States)

^f MAYO CLINIC   (United States)

^g RAMBAM MEDICAL CENTER   (Israel)

^h Eastern Cooperative Oncology Group   (United States)

Author keywords

Acute lymphocytic leukemia; CD56 antigen

Indexed keywords

CD19 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BLAST CELL; CELL LINEAGE; CLINICAL TRIAL; CODON USAGE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE;

ADULT; ANTIGENS, CD19; ANTIGENS, CD56; ANTIGENS, CD7; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; GENOTYPE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; KILLER CELLS, NATURAL; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; NEPRILYSIN; PHENOTYPE; PHILADELPHIA CHROMOSOME; REMISSION INDUCTION;

EID: 0035110167     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200103)66:3<189::AID-AJH1043>3.0.CO;2-A     Document Type: Article

References (40)

1. Classification of natural killer (NK) cell and NK-like T-cell malignancies
2. Classification of T-cell and NK-cell neoplasms based on the REAL classification
3. + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas
4. Natural killer-like T-cell lymphomas: Aggressive lymphomas of T-large granular lymphocytes
5. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
6. + NK lymphomas: Clinicopathological features and prognosis
7. + hematologic malignancies
8. Lymphoproliferative disorders of natural killer cells
9. Immunobiology of acute leukemia
10. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient
11. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin
12. bright phenotype
13. Blastic natural killer cell leukemia/lymphoma: A clinicopathologic study
14. Acute lymphoblastic leukemia/lymphoblastic lymphoma of natural killer (NK) lineage: Quest for another NK-lineage neoplasm
15. Acute leukemia with the phenotype of a natural killer/T cell bipotential precursor
16. Development of human T and natural killer cells
17. Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation
18. Malignancies of natural killer (NK) cell precursor: Myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia
19. Proposals for the classification of the acute leukemias. French-American-British (FAB) co-operative group
20. Acute myeloid leukemia expressing the leucocyte integrin CD11b: A new leukemic syndrome with poor prognosis: Result of an ECOG database analysis
21. Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: Immunological, molecular and functional analyses
22. Expression of CD25 (interleukin-2 receptor α chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: Results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993
23. HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas
24. Failure to detect Epstein-Barr virus DNA in peripheral blood mononuclear cells of most patients with large granular lymphocyte leukemia
25. Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: Major perturbations are preferentially seen with the CD4 T-cell subset
26. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype
27. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833
28. A new approach of acute lymphoblastic leukemia immunophenotypic classification: 1984-1994. The GEIL experience
29. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: An analysis of a prospective trial including 562 tested patients (LALA87)
30. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia. The Southwest Oncology Group Experience
31. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: Results of the German Multicenter Trials GMALL 03/87 and 04/89
32. Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and leukemia group 3 study 8364
33. + non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance
34. Flow cytometry: A useful tool in diagnosing and monitoring patients with natural killer cell neoplasms
35. + NK progenitor
36. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes
37. CD13 - Not just a marker in leukemia typing
38. - progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells
39. Identification of novel B-lineage cells in human fetal bone marrow that co-express CD7